REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mezzion Pharma Co.,Ltd. (South Korea)

Main Activities: Scientific Research and Development Services
Full name: Mezzion Pharma Co.,Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mezzion Pharma Co.,Ltd. is engaged in provision of a pharmaceutical research. The company offers products including Zydena for benign prostatic hyperplasia and erectile dysfunction, and Gonadopin for women infertility. Mezzion Pharma Co.,Ltd. was incorporated in 2002 and is based in Seoul, South Korea.

Headquarters
154-8 C H Building, Samsung1Dong, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Mezzion Pharma Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Mezzion Pharma Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Mezzion Pharma Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Mezzion Pharma Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Mezzion Pharma Co.,Ltd. report to view the information.
Incorporation Date:
September 25, 2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
10.53%
Purchase this report to view the information.
3.74%
Purchase this report to view the information.
1.12%
Purchase this report to view the information.
0.98%
Purchase this report to view the information.
0.12%
Subsidiaries
Mezzion Pharmaceut Cals Inc100
100%
Company Performance
Financial values in the chart are available after Mezzion Pharma Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-72.16%▼
Total operating revenue
-71.05%▼
Operating profit (EBIT)
-5.31%▼
EBITDA
-11.59%▼
Net Profit (Loss) for the Period
71.41%▲
Total assets
-12.61%▼
Total equity
-17.66%▼
Operating Profit Margin (ROS)
-141.05%▼
Net Profit Margin
-0.93%▼
Return on Equity (ROE)
5.27%▲
Debt to Equity Ratio
-1.79%▼
Quick Ratio
-1.18%▼
Cash Ratio
-1.03%▼

Similar companies

Cj Cheiljedang Corporation
 
Green Cross Corporation
Samsung Bioepis Co,.Ltd.
 
Hyundai Autron Co.,Ltd.
Gm Technical Center Korea Co.,Ltd.
 
Merck Advanced Technologies Co.,Ltd.
Ebest Special Purpose Acquisition 2 Co., Ltd.
 
Cellivery Therapeutics, Inc.
Olix Pharmaceuticals, Inc.
 
Dna Link, Inc.
CJ Bioscience, Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo